vTv Therapeutics Inc.
VTVTNasdaqCIK 1641489HealthcareFiscal year ends Dec 31
Reports and events: 291 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0620:31 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641489-26-000032 |
| 2026-08-0620:24 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001641489-26-000030 |
| 2026-08-0620:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-26-000029 |
| 2026-06-2920:14 ET | 8-K | 5.07 Shareholder vote results | 0001641489-26-000024 |
| 2026-05-1321:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-221971 |
| 2026-05-1320:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001641489-26-000020 |
| 2026-05-1320:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-26-000019 |
| 2026-04-2820:21 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001641489-26-000015 |
| 2026-03-1020:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-26-000012 |
| 2026-03-1020:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-26-000011 |
| 2026-03-1020:32 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001641489-26-000010 |
| 2026-02-2612:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-26-000005 |
| 2026-02-0221:18 ET | 8-K | 1.01 Entry into a material agreement | 0001641489-26-000002 |
| 2025-12-1922:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641489-25-000066 |
| 2025-12-0921:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001699737-25-000029 |
| 2025-11-0621:32 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001641489-25-000060 |
| 2025-11-0621:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000058 |
| 2025-09-2521:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001699737-25-000004 |
| 2025-09-1017:03 ET | 8-K | 7.01 Regulation FD disclosure | 0001641489-25-000055 |
| 2025-09-0323:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-023605 |
| 2025-09-0213:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-193486 |
| 2025-08-1220:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641489-25-000053 |
| 2025-08-1220:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000051 |
| 2025-06-1220:23 ET | 8-K | 5.07 Shareholder vote results | 0001641489-25-000038 |
| 2025-05-1920:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641489-25-000032 |
| 2025-05-1613:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-25-000030 |
| 2025-05-1520:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000028 |
| 2025-05-1520:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641489-25-000026 |
| 2025-04-2520:20 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001641489-25-000024 |
| 2025-04-1120:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641489-25-000018 |
| 2025-03-3120:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-25-000016 |
| 2025-03-2020:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641489-25-000014 |
| 2025-03-2020:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-25-000013 |
| 2025-03-1713:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641489-25-000010 |
| 2025-02-2721:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641489-25-000005 |
| 2025-01-1313:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641489-25-000003 |
| 2024-11-1221:43 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001641489-24-000075 |
| 2024-11-1221:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-24-000073 |
| 2024-10-2520:29 ET | 8-K | 1.02 Termination of a material agreement | 0001641489-24-000069 |
| 2024-08-0820:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-24-000063 |
| 2024-08-0820:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001641489-24-000061 |
| 2024-07-2620:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641489-24-000057 |
| 2024-07-0220:41 ET | 8-K | 1.01 Entry into a material agreement | 0001641489-24-000054 |
| 2024-06-1420:22 ET | 8-K | 5.07 Shareholder vote results | 0001641489-24-000045 |
| 2024-05-0920:32 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001641489-24-000029 |
| 2024-05-0920:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641489-24-000027 |
| 2024-04-2520:23 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001641489-24-000023 |
| 2024-03-2620:35 ET | 8-K | 8.01 Other events | 0001641489-24-000020 |
| 2024-03-2220:57 ET | SC 13D/A | Ownership report, active investor, amended | 0000950142-24-000754 |
| 2024-03-1411:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641489-24-000014 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.